Preparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines

Yusra A Alyafee,1,2 Manal Alaamery,1 Shahad Bawazeer,1 Mansour S Almutairi,1 Badr Alghamdi,1 Nawaf Alomran,1 Atia Sheereen,1 Maha Daghestani,2 Salam Massadeh1,3 1Developmental Medicine Department, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sci...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alyafee YA, Alaamery M, Bawazeer S, Almutairi MS, Alghamdi B, Alomran N, Sheereen A, Daghestani M, Massadeh S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/4ff0664acf6c454795d17de4b2e197d8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4ff0664acf6c454795d17de4b2e197d8
record_format dspace
spelling oai:doaj.org-article:4ff0664acf6c454795d17de4b2e197d82021-12-02T02:11:17ZPreparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines1178-2013https://doaj.org/article/4ff0664acf6c454795d17de4b2e197d82017-12-01T00:00:00Zhttps://www.dovepress.com/preparation-of-anastrozole-loaded-peg-pla-nanoparticles-evaluation-of--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yusra A Alyafee,1,2 Manal Alaamery,1 Shahad Bawazeer,1 Mansour S Almutairi,1 Badr Alghamdi,1 Nawaf Alomran,1 Atia Sheereen,1 Maha Daghestani,2 Salam Massadeh1,3 1Developmental Medicine Department, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, King AbdulAziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia; 2Department of Zoology/College of Science/King Saud University (KSU), Riyadh, Kingdom of Saudi Arabia; 3College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, King Abdulaziz Medical City, Ministry of National Guard, Health Affairs, Riyadh, Kingdom of Saudi Arabia Purpose: Anastrozole (ANS) is an aromatase inhibitor that is widely used as a treatment for breast cancer in postmenopausal women. Despite the wide use of ANS, it is associated with serious side effects due to uncontrolled delivery. In addition, ANS exhibits low solubility and short plasma half-life. Nanotechnology-based drug delivery has the potential to enhance the efficacy of drugs and overcome undesirable side effects. In this study, we aimed to prepare novel ANS-loaded PLA-PEG-PLA nanoparticles (ANS-NPs) and to compare the apoptotic response of MCF-7 cell line to both ANS and ANS-loaded NPs.Method: ANS-NPs were synthesized using double emulsion method and characterized using different methods. The apoptotic response was evaluated by assessing cell viability, morphology, and studying changes in the expression of MAPK3, MCL1, and c-MYC apoptotic genes in MCF-7 cell lines.Results: ANS was successfully encapsulated within PLA-PEG-PLA, forming monodisperse therapeutic NPs with an encapsulation efficiency of 67%, particle size of 186±27.13, and a polydispersity index of 0.26±0.11 with a sustained release profile extended over 144 hours. In addition, results for cell viability and for gene expression represent a similar apoptotic response between the free ANS and ANS-NPs.Conclusion: The synthesized ANS-NPs showed a similar therapeutic effect as the free ANS, which provides a rationale to pursue pre-clinical evaluation of ANS-NPs on animal models. Keywords: anastrozole, PLA-PEG-PLA, anti-apoptosis, gene expression, therapeutic nanoparticlesAlyafee YAAlaamery MBawazeer SAlmutairi MSAlghamdi BAlomran NSheereen ADaghestani MMassadeh SDove Medical PressarticleAnastrozolePLA-PEG-PLAAnti-apoptosisgene expressiontherapeutic nanoparticlesMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 199-208 (2017)
institution DOAJ
collection DOAJ
language EN
topic Anastrozole
PLA-PEG-PLA
Anti-apoptosis
gene expression
therapeutic nanoparticles
Medicine (General)
R5-920
spellingShingle Anastrozole
PLA-PEG-PLA
Anti-apoptosis
gene expression
therapeutic nanoparticles
Medicine (General)
R5-920
Alyafee YA
Alaamery M
Bawazeer S
Almutairi MS
Alghamdi B
Alomran N
Sheereen A
Daghestani M
Massadeh S
Preparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines
description Yusra A Alyafee,1,2 Manal Alaamery,1 Shahad Bawazeer,1 Mansour S Almutairi,1 Badr Alghamdi,1 Nawaf Alomran,1 Atia Sheereen,1 Maha Daghestani,2 Salam Massadeh1,3 1Developmental Medicine Department, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, King AbdulAziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia; 2Department of Zoology/College of Science/King Saud University (KSU), Riyadh, Kingdom of Saudi Arabia; 3College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, King Abdulaziz Medical City, Ministry of National Guard, Health Affairs, Riyadh, Kingdom of Saudi Arabia Purpose: Anastrozole (ANS) is an aromatase inhibitor that is widely used as a treatment for breast cancer in postmenopausal women. Despite the wide use of ANS, it is associated with serious side effects due to uncontrolled delivery. In addition, ANS exhibits low solubility and short plasma half-life. Nanotechnology-based drug delivery has the potential to enhance the efficacy of drugs and overcome undesirable side effects. In this study, we aimed to prepare novel ANS-loaded PLA-PEG-PLA nanoparticles (ANS-NPs) and to compare the apoptotic response of MCF-7 cell line to both ANS and ANS-loaded NPs.Method: ANS-NPs were synthesized using double emulsion method and characterized using different methods. The apoptotic response was evaluated by assessing cell viability, morphology, and studying changes in the expression of MAPK3, MCL1, and c-MYC apoptotic genes in MCF-7 cell lines.Results: ANS was successfully encapsulated within PLA-PEG-PLA, forming monodisperse therapeutic NPs with an encapsulation efficiency of 67%, particle size of 186±27.13, and a polydispersity index of 0.26±0.11 with a sustained release profile extended over 144 hours. In addition, results for cell viability and for gene expression represent a similar apoptotic response between the free ANS and ANS-NPs.Conclusion: The synthesized ANS-NPs showed a similar therapeutic effect as the free ANS, which provides a rationale to pursue pre-clinical evaluation of ANS-NPs on animal models. Keywords: anastrozole, PLA-PEG-PLA, anti-apoptosis, gene expression, therapeutic nanoparticles
format article
author Alyafee YA
Alaamery M
Bawazeer S
Almutairi MS
Alghamdi B
Alomran N
Sheereen A
Daghestani M
Massadeh S
author_facet Alyafee YA
Alaamery M
Bawazeer S
Almutairi MS
Alghamdi B
Alomran N
Sheereen A
Daghestani M
Massadeh S
author_sort Alyafee YA
title Preparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines
title_short Preparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines
title_full Preparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines
title_fullStr Preparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines
title_full_unstemmed Preparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines
title_sort preparation of anastrozole loaded peg-pla nanoparticles: evaluation of apoptotic response of breast cancer cell lines
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/4ff0664acf6c454795d17de4b2e197d8
work_keys_str_mv AT alyafeeya preparationofanastrozoleloadedpegplananoparticlesevaluationofapoptoticresponseofbreastcancercelllines
AT alaamerym preparationofanastrozoleloadedpegplananoparticlesevaluationofapoptoticresponseofbreastcancercelllines
AT bawazeers preparationofanastrozoleloadedpegplananoparticlesevaluationofapoptoticresponseofbreastcancercelllines
AT almutairims preparationofanastrozoleloadedpegplananoparticlesevaluationofapoptoticresponseofbreastcancercelllines
AT alghamdib preparationofanastrozoleloadedpegplananoparticlesevaluationofapoptoticresponseofbreastcancercelllines
AT alomrann preparationofanastrozoleloadedpegplananoparticlesevaluationofapoptoticresponseofbreastcancercelllines
AT sheereena preparationofanastrozoleloadedpegplananoparticlesevaluationofapoptoticresponseofbreastcancercelllines
AT daghestanim preparationofanastrozoleloadedpegplananoparticlesevaluationofapoptoticresponseofbreastcancercelllines
AT massadehs preparationofanastrozoleloadedpegplananoparticlesevaluationofapoptoticresponseofbreastcancercelllines
_version_ 1718402647909728256